Relmada Therapeutics (RLMD) vs Turn Therapeutics (TTRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Turn Therapeutics (TTRX) has outperformed Relmada Therapeutics (RLMD) over the past year, gaining 72.9% versus a gain of 63.3%. Turn Therapeutics is the larger company by market cap ($345.9 million vs $338.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RLMD | TTRX |
|---|---|---|
| Share price | $3.17 | $11.39 |
| Market cap | $338.14M | $345.89M |
| 1-day change | -2.46% | -5.87% |
| YTD return | -32.71% | +207.11% |
| 1-year return | +63.32% | +72.86% |
| 5-year return | -86.25% | — |
| EPS (TTM) | $-0.91 | $-0.29 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.00 | $26.50 |
| 52-week low | $1.80 | $2.57 |
| Distance from 52-week high | -60.38% | -57.02% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +239.12% | +119.49% |
| Average volume | 1.33M | 111.72K |
| Shares outstanding | 106.67M | 30.37M |
| Employees | 17 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Relmada Therapeutics
RLMD stock →Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 17 employees
About Turn Therapeutics
TTRX stock →Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
RLMD vs TTRX FAQ
Which is bigger, Relmada Therapeutics or Turn Therapeutics?
Turn Therapeutics (TTRX) is larger, with a market capitalization of $345.89M compared with $338.14M for Relmada Therapeutics (RLMD).
Which stock has performed better over the past year, RLMD or TTRX?
TTRX returned +72.86% over the past 12 months, compared with +63.32% for RLMD (price return, excluding dividends). Past performance does not predict future results.
Are Relmada Therapeutics and Turn Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.